Berotralstat is now the first targeted oral prophylactic for this indication.
FULL DETAILS: www.contemporarypediatrics.com/view/fda-app...
Berotralstat is now the first targeted oral prophylactic for this indication.
FULL DETAILS: www.contemporarypediatrics.com/view/fda-app...
The federal agency has approved GSK's gepotidacin (Blujepa) as an oral option to treat uncomplicated urogenital #gonorrhea in patients aged 12 years and older weighing at least 45 kg.
Full details: www.contemporarypediatrics.com/view/fda-app...
The federal agency has approved GSK's gepotidacin (Blujepa) as an oral option to treat uncomplicated urogenital #gonorrhea in patients aged 12 years and older weighing at least 45 kg.
Full details: www.contemporarypediatrics.com/view/fda-app...
The FDA is launching a safety review of #RSV preventive monoclonal antibodies #nirsevimab and #clesrovimab. Reuters reported that FDA officials made inquiries into the RSV preventive therapies in the summer. #medsky
Full details: www.contemporarypediatrics.com/view/reports...
The FDA is launching a safety review of #RSV preventive monoclonal antibodies #nirsevimab and #clesrovimab. Reuters reported that FDA officials made inquiries into the RSV preventive therapies in the summer. #medsky
Full details: www.contemporarypediatrics.com/view/reports...
Watch:
www.contemporarypediatrics.com/view/hepatit...
Watch:
www.contemporarypediatrics.com/view/hepatit...
The Centers for Disease Control and Prevention's ACIP has voted to pass a pair of updated recommendations related to the #hepatitis B virus vaccine and timing among infants.
View the exact voting language and how the committee voted, here: www.contemporarypediatrics.com/view/acip-vo...
The Centers for Disease Control and Prevention's ACIP has voted to pass a pair of updated recommendations related to the #hepatitis B virus vaccine and timing among infants.
View the exact voting language and how the committee voted, here: www.contemporarypediatrics.com/view/acip-vo...
Watch the full interview: www.contemporarypediatrics.com/view/joshua-...
Watch the full interview: www.contemporarypediatrics.com/view/joshua-...
#Pediatrics #Immunology #RareDisease #GeneTherapy
READ MORE: www.contemporarypediatrics.com/view/first-p...
#Pediatrics #Immunology #RareDisease #GeneTherapy
READ MORE: www.contemporarypediatrics.com/view/first-p...
View some case details below, then click the link for more information and to make your diagnosis.
Can you diagnose this patient?
View more: www.contemporarypediatrics.com/view/can-you...
View some case details below, then click the link for more information and to make your diagnosis.
Can you diagnose this patient?
View more: www.contemporarypediatrics.com/view/can-you...
The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky
More details to come on contemporarypediatrics.com.
The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky
More details to come on contemporarypediatrics.com.
Arcutis stated the topical formulation will be available in pharmacies this week.
www.contemporarypediatrics.com/view/lawrenc...
Arcutis stated the topical formulation will be available in pharmacies this week.
www.contemporarypediatrics.com/view/lawrenc...
Click here to read this Q&A from #IDWeek:
www.contemporarypediatrics.com/view/sarah-m...
Click here to read this Q&A from #IDWeek:
www.contemporarypediatrics.com/view/sarah-m...
Lebrikizumab-lbkz (Ebglyss; EliLillyandCo) demonstrated similar levels of #skin clearance in patients with #atopicdermatitis when administered once every 8 weeks compared to every 4 weeks.
MORE: www.contemporarypediatrics.com/view/fall-cl...
Lebrikizumab-lbkz (Ebglyss; EliLillyandCo) demonstrated similar levels of #skin clearance in patients with #atopicdermatitis when administered once every 8 weeks compared to every 4 weeks.
MORE: www.contemporarypediatrics.com/view/fall-cl...
Roflumilast cream 0.15% and 0.05% demonstrated improved #itch and reduced impact of AD on sleep in patients 2 years and up. #medsky #pedsky
Full coverage: www.contemporarypediatrics.com/view/fall-cl...
Roflumilast cream 0.15% and 0.05% demonstrated improved #itch and reduced impact of AD on sleep in patients 2 years and up. #medsky #pedsky
Full coverage: www.contemporarypediatrics.com/view/fall-cl...
Watch our full interview here: www.contemporarypediatrics.com/view/using-e...
Watch our full interview here: www.contemporarypediatrics.com/view/using-e...
Today, the FDA accepted MannKind Corporation's sBLA for #Afrezza Inhalation Powder to include children and adolescents with type 1 or type 2 #diabetes.
READ MORE:
www.contemporarypediatrics.com/view/fda-acc...
Today, the FDA accepted MannKind Corporation's sBLA for #Afrezza Inhalation Powder to include children and adolescents with type 1 or type 2 #diabetes.
READ MORE:
www.contemporarypediatrics.com/view/fda-acc...
More:
hubs.li/Q03LwvXw0
More:
hubs.li/Q03LwvXw0
Read more: hubs.li/Q03Lwwht0
Read more: hubs.li/Q03Lwwht0
More on this association: hubs.li/Q03LwqWB0
More on this association: hubs.li/Q03LwqWB0
More on this emerging trend: www.contemporarypediatrics.com/view/sodium-...
More on this emerging trend: www.contemporarypediatrics.com/view/sodium-...
Watch our brief discussion with Straub here: www.contemporarypediatrics.com/view/diane-s...
Watch our brief discussion with Straub here: www.contemporarypediatrics.com/view/diane-s...
Melanie Cree, MD, discussed approaches to evaluating primary amenorrhea and managing conditions such as Turner syndrome, polycystic ovary syndrome (PCOS), and the female athlete triad.
Full interview: www.contemporarypediatrics.com/view/melanie...
Melanie Cree, MD, discussed approaches to evaluating primary amenorrhea and managing conditions such as Turner syndrome, polycystic ovary syndrome (PCOS), and the female athlete triad.
Full interview: www.contemporarypediatrics.com/view/melanie...
Full study details: www.contemporarypediatrics.com/view/emergen...
Full study details: www.contemporarypediatrics.com/view/emergen...
Follow us on our website, contemporarypediatrics.com, for continued coverage, including expert interviews.
More: www.contemporarypediatrics.com/view/aap-202...
Follow us on our website, contemporarypediatrics.com, for continued coverage, including expert interviews.
More: www.contemporarypediatrics.com/view/aap-202...
Full data analysis: www.contemporarypediatrics.com/view/cdc-rep...
Full data analysis: www.contemporarypediatrics.com/view/cdc-rep...